CLINICAL_TRIALS
trial_result
· 2023-10-26
Clinical Trial Update: Correlate BRCA1 Protein Expression With Response to DNA Damaging Chemotherapy [Phase 2]
Summary
Phase 2 trial updating correlation of BRCA1 protein expression with response to DNA-damaging chemotherapy in breast cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Arizona | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2023-10-26